全文获取类型
收费全文 | 517篇 |
免费 | 33篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 13篇 |
妇产科学 | 26篇 |
基础医学 | 69篇 |
口腔科学 | 12篇 |
临床医学 | 47篇 |
内科学 | 123篇 |
皮肤病学 | 3篇 |
神经病学 | 33篇 |
特种医学 | 53篇 |
外科学 | 33篇 |
综合类 | 7篇 |
预防医学 | 36篇 |
眼科学 | 2篇 |
药学 | 27篇 |
中国医学 | 2篇 |
肿瘤学 | 73篇 |
出版年
2022年 | 4篇 |
2021年 | 5篇 |
2020年 | 6篇 |
2019年 | 9篇 |
2018年 | 21篇 |
2017年 | 13篇 |
2016年 | 7篇 |
2015年 | 13篇 |
2014年 | 16篇 |
2013年 | 20篇 |
2012年 | 32篇 |
2011年 | 18篇 |
2010年 | 19篇 |
2009年 | 13篇 |
2008年 | 21篇 |
2007年 | 29篇 |
2006年 | 26篇 |
2005年 | 21篇 |
2004年 | 24篇 |
2003年 | 9篇 |
2002年 | 23篇 |
2001年 | 19篇 |
2000年 | 12篇 |
1999年 | 13篇 |
1998年 | 13篇 |
1997年 | 17篇 |
1996年 | 11篇 |
1995年 | 8篇 |
1994年 | 15篇 |
1993年 | 13篇 |
1992年 | 5篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 12篇 |
1988年 | 6篇 |
1987年 | 4篇 |
1986年 | 7篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 5篇 |
1973年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有561条查询结果,搜索用时 15 毫秒
81.
Yang XR Chang-Claude J Goode EL Couch FJ Nevanlinna H Milne RL Gaudet M Schmidt MK Broeks A Cox A Fasching PA Hein R Spurdle AB Blows F Driver K Flesch-Janys D Heinz J Sinn P Vrieling A Heikkinen T Aittomäki K Heikkilä P Blomqvist C Lissowska J Peplonska B Chanock S Figueroa J Brinton L Hall P Czene K Humphreys K Darabi H Liu J Van 't Veer LJ van Leeuwen FE Andrulis IL Glendon G Knight JA Mulligan AM O'Malley FP Weerasooriya N John EM Beckmann MW Hartmann A Weihbrecht SB Wachter DL Jud SM 《Journal of the National Cancer Institute》2011,103(3):250-263
82.
Nadine Beetz Michael D. Harrison Marc Brede Xiangang Zong Michal J. Urbanski Anika Sietmann Jennifer Kaufling Stefan Lorkowski Michel Barrot Mathias W. Seeliger Maria Augusta Vieira-Coelho Pavel Hamet Daniel Gaudet Ondrej Seda Johanne Tremblay Theodore A. Kotchen Mary Kaldunski Rolf Nüsing Bela Szabo Howard J. Jacob Allen W. Cowley Jr. Martin Biel Monika Stoll Martin J. Lohse Ulrich Broeckel Lutz Hein 《The Journal of clinical investigation》2011,121(1):454
83.
84.
Jacques E. Gaudet Rohan R. Walvekar Moises A. Arriaga Michael D. Dileo Daniel W. Nuss Anna M. Pou Joseph Hagan James Lin 《Skull base》2010,20(6):409-414
The objectives are to evaluate the applicability of the Pittsburgh staging system (PSS) (designed for primary temporal bone malignancies) to advanced periauricular cutaneous malignancies with temporal bone involvement and to study treatment outcomes and prognostic factors predicting recurrence-free survival. Ten patients with advanced periauricular cutaneous malignancy with temporal bone involvement were identified. Patients with primary temporal bone or parotid gland malignancies were excluded. All patients were clinically T4 at presentation by the American Joint Committee on Cancer (AJCC) staging system. Using Pittsburgh staging, six were T1 (stage I) and four were T4 (stage III). The mean follow-up was 13.6 months (3 to 24 months). Patients with basal cell carcinoma were managed with wide local excision and lateral temporal bone resection (WLE/LTBR) without adjuvant therapy. Two of three (66%) are alive and free of disease; one patient died of other causes. Treatment for squamous cell carcinoma patients involved multimodality therapy. Kaplan–Meier survival curves show a worse prognosis in terms of disease-specific survival for patients with higher-staged PSS tumors. This did not reach statistical significance. The PSS may provide additional prognostic information on advanced cutaneous malignancies of the temporal bone over the more widely used AJCC staging system. However, further prospective multicenter studies with larger sample size are required to validate our findings. Basal cell carcinoma was well controlled with WLE/LTBR alone without adjuvant therapy, whereas squamous cell carcinoma required multimodality therapy: WLE/LTBR and postoperative radiation with or without chemotherapy. 相似文献
85.
86.
S. M. Domchek M. M. Gaudet J. E. Stopfer M. H. Fleischaut J. Powers N. Kauff K. Offit K. L. Nathanson M. Robson 《Breast cancer research and treatment》2010,119(2):409-414
Genetic testing for BRCA1 and BRCA2 mutations in family members of individuals with known deleterious mutations can distinguish between patients at high risk
of disease and those who are not. Some studies have suggested that individuals testing negative for known familial mutations
(true negatives), may still have a higher risk of breast cancer (BC) than the general population. We have examined a prospectively
followed cohort of true negative women in the US. Subjects were close relatives of known BRCA1 and BRCA2 mutation carriers who had undergone genetic testing, were negative for the known familial mutation, and were unaffected at
the time of genetic testing. Standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated using SEER
incidence rates. Among 375 true negatives, two invasive and two in situ BC and no ovarian cancers were diagnosed with mean
follow up of 4.9 years (total of 1,962 person-years). Four invasive BC were expected, whereas two were observed, for an age-adjusted
SIR of 0.52 (95% CI 0.13–2.09). We observed more cases of in situ BC (n = 2) than were expected (n = 0.9; SIR = 2.30; 95% CI 0.57–9.19). There were no cases of ovarian cancer observed; 0.4 case was expected. In this prospective
study of women who were unaffected at the time of genetic testing and who were negative for the known familial mutation in
BRCA1/2, no excess risk of invasive BC was observed. Our data suggest that such women in the US should adhere to population-based
guidelines for breast cancer screening. 相似文献
87.
88.
Amy Russell Stephanie Gillespie Suma Satya Laura M. Gaudet 《Journal d'obstetrique et gynecologie du Canada》2013,35(9):802-809
ObjectiveMaternity care providers can use pre-pregnancy weight (PPW) and gestational weight gain (GWG) as markers for difficult delivery, and frequently obtain this information directly from the patient. The goal of this study was to determine whether women report their PPW and GWG correctly at the end of pregnancy.MethodsWe performed a prospective cohort study of 189 women delivering between June 1,2011, and July 31,2011, at the Saint John Regional Hospital or the Moncton Hospital in New Brunswick. Self- reported PPW and GWG were compared with measured weights obtained from the antenatal chart and upon presentation for delivery. Patient characteristics, BMI classification, and accuracy and degree of error in recall were assessed.ResultsThe majority of respondents were under 30 years of age (63.4%) and were delivering at term (96.3%). Ninety women (47.6%) were having their first baby. A record of weight measured in the first trimester was available for 98 respondents (51.9%); using this information, 44 women (44.9%) were determined to be overweight or obese at delivery. Approximately one third of women with a normal BMI were not able to recall their PPW or GWG accurately (± 1 kg). Among all BMI classes, there was a consistent pattern of under-reporting of PPW (by a mean of 1.52 kg) and over-reporting of GWG (by a mean of 1.61 kg), but several extreme outliers were identified.ConclusionAt the time of delivery, under-reporting of PPW and over-reporting of GWG are common and difficult to predict. Maternity care providers should be aware of this discrepant reporting of PPW and GWG and recognize the implications for intrapartum management and postpartum weight loss. 相似文献
89.
Darine El-Chaar Sara A. Finkelstein Xiaowen Tu Deshayne B. Fell Laura Gaudet Jacques Sylvain George Tawagi Shi Wu Wen Mark Walker 《Journal d'obstetrique et gynecologie du Canada》2013,35(3):224-233
ObjectiveNationally, rates of obesity continue to rise, resulting in increased health concerns for women of reproductive age Identifying the impact of maternal obesity on obstetrical outcomes is important to enhance patient care.MethodsWe conducted a retrospective cohort study of 6674 women who delivered a singleton infant at ≥ 20 weeks’ gestation between December 1, 2007, and March 31, 2010, at The Ottawa Hospital. Maternal pre-pregnancy BMI was used to classify women into normal, overweight, and obese (class I/II/III) categories according to WHO classifications. Obstetrical outcomes among obese women were compared with those of women with normal BMI Multivariable regression models were used to determine adjusted odds ratios and 95% confidence intervals.ResultsCompared with women with normal BMI, obese women had significantly higher rates of preeclampsia, gestational hypertension, and gestational diabetes, and these rates increased with increasing BMI (trend-test P < 0.001). There was a significant increase in rates of induction of labour in the obesity categories, from 25 3% in women with normal BMI to 42 9% in women with class III morbid obesity (aOR 1.67; 95% CI 1.43 to 1.93). Rates of primary Caesarean section rose with increasing BMI and were highest in women with class III morbid obesity (36 2% vs 22 1% in women with normal BMI) (aOR 1.46; 95% CI 1. 23 to 1.73).ConclusionIncreasing BMI is associated with increasing rates of preeclampsia, gestational hypertension, and gestational diabetes There is a significant increase in rates of induction of labour with increasing obesity class, and a significantly increased Caesarean section rate with higher BMI Obstetrical care providers should counsel obese patients about the risks they face and the importance of weight loss before pregnancy. 相似文献
90.
Cerebral palsy remains a significant cause of perinatal morbidity in medically developed countries. Human epidemiologic data suggest a relationship between cerebral palsy and chorioamnionitis mediated by proinflammatory cytokines. This association has been confirmed by experimental data from human and animal research that demonstrate an increase in cytokine levels in the amniotic fluid of cases of white matter damage. Recent evidence suggests this damage is the result of a fetal inflammatory response initiated in response to placental inflammation. The strong association between cerebral palsy and chorioamnionitis warrants additional investigation into the mechanisms by which white matter damage is initiated and into possible neuroprotective treatments to prevent the development of cerebral palsy. 相似文献